We are live on ! Find out more
RPTX

Repare Therapeutics
RPTX

Delisted

RPTX was delisted on the 27th of January, 2026.

Back to rankings

63 hedge funds and large institutions have $858M invested in Repare Therapeutics in 2020 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 12 increasing their positions, 13 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

800% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 3

62% more funds holding

Funds holding: 39 → 63 (+24)

18% more capital invested

Capital invested by funds: $729M → $858M (+$130M)

2.97% more ownership

Funds ownership: 64.97% → 67.93% (+3%)

0% more funds holding in top 10

Funds holding in top 10: 5 → 5 (0)

8% less repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 13

Holders
63
Holders Change
+24
Holders Change %
+61.54%
% of All Funds
1.11%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
27
Increased
12
Reduced
13
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AIM
ARK Investment Management
Florida
+$19M
2
BlackRock
BlackRock
New York
+$10.9M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
+$9.04M
4
RG
Redmile Group
California
+$7.25M
5
Bank of Montreal
Bank of Montreal
Ontario, Canada
+$6.4M

Top Sellers

Rank Fund Capital Flow
1
LGM
Logos Global Management
California
-$8.96M
2
IC
Ikarian Capital
Texas
-$5.86M
3
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$3M
4
Millennium Management
Millennium Management
New York
-$2.83M
5
BI
BVF Inc
California
-$2.77M
Name Holding Trade Value Shares
Change 		Change in
Stake
AC
26
Athanor Capital
New York
$744K +$648K +21,701 New
Geode Capital Management
27
Geode Capital Management
Massachusetts
$734K – – –
SSA
28
Schonfeld Strategic Advisors
New York
$728K +$633K +21,200 New
Swiss National Bank
29
Swiss National Bank
Switzerland
$713K +$621K +20,800 New
HF
30
HRT Financial
New York
$675K +$588K +19,683 New
Ensign Peak Advisors
31
Ensign Peak Advisors
Utah
$666K – – –
Goldman Sachs
32
Goldman Sachs
New York
$613K +$534K +17,883 New
T. Rowe Price Associates
33
T. Rowe Price Associates
Maryland
$578K +$504K +16,853 New
Norges Bank
34
Norges Bank
Norway
$513K -$1.05M -35,030 -70%
PCM
35
Pentwater Capital Management
Florida
$463K +$149K +5,000 +59%
DekaBank Deutsche Girozentrale
36
DekaBank Deutsche Girozentrale
Germany
$440K +$385K +12,900 New
SFI
37
Susquehanna Fundamental Investments
Pennsylvania
$430K -$143K -4,771 -28%
Citadel Advisors
38
Citadel Advisors
Florida
$396K +$109K +3,646 +46%
Tudor Investment Corp
39
Tudor Investment Corp
Connecticut
$395K -$362K -12,105 -51%
Allianz Asset Management
40
Allianz Asset Management
Germany
$352K +$307K +10,270 New
HTC
41
Hershey Trust Company
Pennsylvania
$261K +$227K +7,597 New
LSA
42
L & S Advisors
California
$257K +$224K +7,500 New
VEA
43
Virtus ETF Advisers
New York
$256K +$223K +7,469 New
Susquehanna International Group
44
Susquehanna International Group
Pennsylvania
$216K +$188K +6,303 New
Bank of New York Mellon
45
Bank of New York Mellon
New York
$213K +$185K +6,200 New
State Street
46
State Street
Massachusetts
$207K +$180K +6,035 New
CSS
47
Cubist Systematic Strategies
Connecticut
$113K +$98.9K +3,309 New
GGHC
48
Gilder Gagnon Howe & Co
New York
$111K -$90 -3 -0.1%
BCV
49
Banque Cantonale Vaudoise
Switzerland
$103K +$29.9K +1,000 +50%
Wells Fargo
50
Wells Fargo
California
$87K +$76.2K +2,550 New
1
2
3

RPTX Hedge Fund Activity: Q4 2020 in Review

63 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Repare Therapeutics (RPTX) for Q4 2020, worth a combined $858M — up 18% from $729M a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new RPTX positions and 3 closed out — a net gain of 24 holders — while 12 added to existing stakes and 13 trimmed.

The largest buyer was ARK Investment Management, opening a new position worth an estimated $19M. The largest seller was Logos Global Management, cutting an estimated $8.96M.

  • 63 institutional investors held Repare Therapeutics (RPTX) as of Q4 2020, up from 39 in Q3 2020.
  • Funds reported $858M of Repare Therapeutics stock for Q4 2020, up 18% quarter-over-quarter.
  • 27 funds opened new Repare Therapeutics positions in Q4 2020 and 3 closed out, a net change of +24 holders.
  • The largest Repare Therapeutics buyer in Q4 2020 was ARK Investment Management, an estimated $19M added.
  • The largest Repare Therapeutics seller in Q4 2020 was Logos Global Management, an estimated $8.96M sold.

Based on aggregated 13F filings for Q4 2020.